Acta Vet. Brno 2017, 86: 183-188
https://doi.org/10.2754/avb201786020183
Changes in haematological indices following local application of interleukin-1 receptor antagonist protein after tenotomy in rabbits
References
1. Archetti I, Tittarelli C, Cerioli M, Brivio R, Grilli G, Lavazza A 2008: Serum chemistry and hematology values in commercial rabbits: Preliminary data from industrial farms in northern Italy. Proceedings of 9th World Rabbit Congress, 10-13 July, Verona, Italy
2. S, Kuehne N, Winzen R, Doerrie A, Dittrich-Breiholz O, Thakur BK, Kracht M, Holtmann H 2011: Interleukin-1 activates synthesis of interleukin-6 by interfering with a KH-type splicing regulatory protein (KSRP)-dependent translational silencing mechanism. J Biol Chem 286: 33279-33288
<https://doi.org/10.1074/jbc.M111.264754>
3. CH, Gouye JN, Gouze E, Robbins PD, Ghivizzani SC 2004: Osteoarthritis gene therapy. Gene Ther 11: 379-389
<https://doi.org/10.1038/sj.gt.3302196>
4. J, Tardif G, Martel-Pelletier J, Lascau-Coman V, Dupuis M, Moldovan F, Sheppard M, Krishnan BR, Pelletier JP 1999: In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 154: 1159-1169
<https://doi.org/10.1016/S0002-9440(10)65368-0>
5. RM, Schechtsman J, Bennett R, Handel ML, Burmester GR, Tesser J, Modafferi D, Poulakos J, Sun G 2003: Anakinra, a recombinant human interleukin‐1 antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis. Arthritis Rheum 48927-48934
6. T, Schmidt W, Jugmichel D, Horn LC, Josten CH 2011: Histopathology in rabbit Achilles tendon after operative tendolysis (longitudinal fiber incision). Scan J of Med and Sci in Sport 11: 4-8
<https://doi.org/10.1034/j.1600-0838.2001.011001004.x>
7. DD, Ghivizzani SC, Robbins PD, Evans CH, McIlwraith CW 2002: Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 9: 12-20
<https://doi.org/10.1038/sj.gt.3301608>
8. Fudge AM 1999: Laboratory Medicine: Avian and Exotic Pets. WB Saunders Co, Philadelphia.
9. Harkness JE, Wagner JE 1995: The Biology and Medicine of Rabbits and Rodents, Lea&Febiger, Philadelphia.
10. CD, Innes DJ, Savory J, Wills MR 1989: Normal biochemical and hematological values in New Zealand white rabbits. Clin Chem 35: 1777-1779
11. Jain NC 1986: Hematologic techniques. Veterinary Hematology. Lea&Febiger, Philadelphia, pp 80-86
12. A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Molnar C, Ludwiczek O, Atkins MB, Mier JW, Til H 2001: Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood Journal 98: 2720-2725
<https://doi.org/10.1182/blood.V98.9.2720>
13. Kerr M 1989: Veterinary Laboratory Medicine. Clinical Biochemistry and Haematology. Blackwell Scientific Publications
14. Kos J, Radisic B, Smolec O, Brkljaca-Bottegaro N, Kreszinger M, Pecin M 2012: Molecular therapy of osteoarthritis horses and dogs with autologous proteins. Conference proceedings of 5th Croatian Veterinary Congress, Tuheljske toplice, Croatia. pp 415-422
15. A 2007: Rabbit clinical pathology. J Exot Pet Med 16: 135-146
<https://doi.org/10.1053/j.jepm.2007.06.002>
16. Mirutka BM and Rawnley HM 1977: Clinical biochemical and haematological reference values in normal and experimental animals. Masson Publishing USA, Inc. 83: 134-135
17. JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanović D, Fernandes JC, Martel-Pelletier J 1997: In vivo supression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 40: 1012-1019
<https://doi.org/10.1002/art.1780400604>
18. Perlmutter RM, Bear M, Bekker P, Cohen S 2001: Anakinra for the Treatment of Rheumatoid Arthritis. Presentation of FDA, 16th August. Published on Web URL: http:/www.fda.gov/ohrms/dockets/ac/01/slides/3779s1_01_amgen.ppt
19. JD, Wilson AM, Wolman RL 2006: Current concepts in the management of tendon disorders. Rheumatology 45: 508-521
<https://doi.org/10.1093/rheumatology/kel046>
20. RP, Cullor JS, Brooks DL 1999: The observation of reactive thrombocytosis in New Zealand white rabbits in response to experimental Pasteurella multocida infection. Blood Cells Mol Dis 25: 95-102
<https://doi.org/10.1006/bcmd.1999.0233>
21. J, Goodband RD, Chengappa MM, Nelssen JL, Tokach MD, Mcvey DS, Blecha F 1994: Influence of interleukin-1 on neutrophil function and resistance to Streptococcus suis in neonatal pigs. J Leukoc Biol 56: 88-94
<https://doi.org/10.1002/jlb.56.1.88>
22. J 2011: Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein. Vet Clin North Am Equine Pract 27: 275-298
<https://doi.org/10.1016/j.cveq.2011.05.001>
23. G and Jones KD 1990: Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 75: 1305-1310
24. Vennen KM, Mitchell MA 2009: Rabbits. Manual of Exotic Pet Practice, W.B. Saunders, St. Louis, pp 375-405
25. P, Moser C, Frisbie D, Mcilwraith CW, Kawack CE, Krauspe R, Reinecke JA 2007: Autologous conditions serum in the treatment of orthopaedic diseases. Biodrugs 21: 323-332
<https://doi.org/10.2165/00063030-200721050-00004>
26. T, Opolon P, Appell HJ, Meijer H, Wehling P, Mir LM 2004: Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med 25: 582-587
<https://doi.org/10.1055/s-2004-821303>
27. B, Hu J, Man C, Zhu S 2011: Effect of intra-articular administration of interleukin 1 receptor antagonist on cartilage repair in temporomandibular joint. J Craniofac Surg 22: 711-714
<https://doi.org/10.1097/SCS.0b013e31820873c6>
